Filter News
Area of Research
- (-) Neutron Science (16)
- (-) Nuclear Science and Technology (6)
- Advanced Manufacturing (1)
- Biology and Environment (21)
- Clean Energy (57)
- Climate and Environmental Systems (2)
- Computational Biology (1)
- Computational Engineering (2)
- Computer Science (4)
- Energy Sciences (1)
- Fusion and Fission (1)
- Fusion Energy (1)
- Isotopes (15)
- Materials (29)
- Materials for Computing (8)
- Mathematics (1)
- National Security (11)
- Quantum information Science (6)
- Sensors and Controls (1)
- Supercomputing (33)
News Topics
- (-) Biomedical (10)
- (-) Climate Change (1)
- (-) Cybersecurity (1)
- (-) Isotopes (5)
- (-) Quantum Science (5)
- (-) Security (1)
- (-) Space Exploration (3)
- 3-D Printing/Advanced Manufacturing (8)
- Advanced Reactors (8)
- Artificial Intelligence (3)
- Big Data (1)
- Bioenergy (5)
- Biology (2)
- Chemical Sciences (1)
- Composites (1)
- Computer Science (12)
- Coronavirus (8)
- Decarbonization (1)
- Environment (2)
- Fusion (7)
- High-Performance Computing (1)
- Machine Learning (1)
- Materials (3)
- Materials Science (15)
- Mathematics (1)
- Microscopy (2)
- Molten Salt (4)
- Nanotechnology (8)
- National Security (1)
- Neutron Science (44)
- Nuclear Energy (23)
- Physics (5)
- Polymers (1)
- Quantum Computing (1)
- Summit (5)
- Sustainable Energy (2)
- Transformational Challenge Reactor (3)
- Transportation (3)
Media Contacts
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.